Published: November 03, 2012
Press Release
Advancing Understanding of Treatment Through Clinical Trials
Studies investigate the potential of several drugs for the treatment of patients with diabetes or kidney disease
Highlights
• Aliskiren on top of standard therapy does not seem to help type 2 diabetic patients at high risk for developing heart and kidney problems.
• Tolvaptan benefits patients with autosomal dominant polycystic kidney disease.
• Cinacalcet does not significantly reduce the risk of premature death or major heart-related events in dialysis patients with secondary hyperparathyroidism.
Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease.
To read the complete release at NewsBlaze,
Advancing Understanding of Treatment Through Clinical Trials,
Click here
The competition which was intended to encourage the integration of children from different ethnic communities in London area and gives the children a chance to practice their football skills was financed by the Enfield council and co-organized by th
The Department of State hosts the third U.S.-New Zealand Strategic Dialogue this week.
The instructors are conducting the five-day course which is taking place at the National technical centre.
President Jonathan reportedly ordered more troops to be sent to the north-eastern states to stop the flow of insurgency and violence.
US admits more refugees each year than all other resettlement countries combined more than three million since 1975.
In a press statement issued at the Djibouti Football Federation headquarters in the capital Djibouti on Saturday, President Souleiman Hassan Waberi, himself a FIFA commissioner has outlined the importance of the FIFA delegation visit to his country
